New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
19:03 EDTARWR, IDRA, AGEN, HAIN, CHRW, IDIX, OCLR, GNW, MYGN, MMMOn The Fly: After Hours Movers
UP AFTER EARNINGS: Myriad Genetics (MYGN), up 14.5%... Genworth (GNW), up 5%... Oclaro (OCLR), up 5.6%. ALSO HIGHER: 3M (MMM), up 2% after the Dow member announced a $12B share repurchase plan... Idenix Pharmaceuticals (IDIX), up 7.3% after investment firm Baupost Group raised its stake in the company to more than 35% from roughly 27% and disclosed it was granted observer rights for meetings of Idenix's board and committees. DOWN AFTER EARNINGS: C.H. Robinson (CHRW), down 6.4%... Hain Celestial (HAIN), down 7.9%. ALSO LOWER: Agenus (AGEN), down 6.2% after announcing a public offering of common stock... Idera Pharmaceuticals (IDRA), down 3.8% after filing to sell common stock and warrants... Arrowhead Research (ARWR), down 3% after reporting a larger-than-expected quarterly loss and filing a $200M mixed securities shelf.
News For MMM;MYGN;GNW;OCLR;IDIX;CHRW;HAIN;AGEN;IDRA;ARWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 13, 2014
10:08 EDTGNWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:19 EDTGNWGenworth upgraded to Outperform from Market Perform at Keefe Bruyette
Subscribe for More Information
07:12 EDTARWROligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
October 10, 2014
16:18 EDTAGENAgenus files $150M mixed securities shelf
12:11 EDTARWROptions with increasing implied volatility
Subscribe for More Information
October 9, 2014
14:54 EDTMYGNCapital World Investors reports 10.5% passive stake in Myriad Genetics
11:00 EDTARWROptions with increasing implied volatility
Options with increasing implied volatility: ARWR PBR EXXI PWE GST GLNG WTW AFSI ETE VALE
10:00 EDTARWROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:38 EDTARWRArrowhead price target lowered to $12 from $24 at Piper Jaffray
Subscribe for More Information
08:33 EDTARWRArrowhead issues letter to shareholders regarding ARC-520
Subscribe for More Information
06:18 EDTARWRArrowhead downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Arrowhead to Sector Perform citing low-end efficacy in the AASLD abstract. Price target lowered to $9.
05:50 EDTARWRStocks with implied volatility movement; ARWR TKMR
Stocks with implied volatility movement; Arrowhead (ARWR) 158, Tekmira (TKMR) 130 according to iVolatility.
October 8, 2014
16:26 EDTARWROn The Fly: Closing Wrap
Subscribe for More Information
16:09 EDTMYGNMyriad Genetics appoints former LabCorp executive Riggsbee as CFO
Myriad Genetics (MYGN) announced the appointment of R. Bryan Riggsbee as executive vice president, CFO, and Treasurer effective October 16. Jim Evans will continue in his role as CFO through the transition to Riggsbee, the company stated. Riggsbee most recently served as the senior vice president, Corporate Finance at Laboratory Corporation of America (LH).
13:12 EDTARWRArrowhead risk/reward favorable, says Deutsche Bank
Subscribe for More Information
11:48 EDTARWRArrowhead sell-off overdone, long-term view unchanged, says Jefferies
Subscribe for More Information
11:10 EDTARWROptions with increasing implied volatility
Subscribe for More Information
10:55 EDTARWRArrowhead ARC-520 treatment effect much lower than expected, TheStreet says
Subscribe for More Information
10:46 EDTARWRArrowhead plunges after HepB data abstract posted
Subscribe for More Information
10:06 EDTCHRWStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use